Why mismatch negativity continues to hold potential in probing altered brain function in schizophrenia

Abstract The brain potential known as mismatch negativity (MMN) is one of the most studied indices altered function in schizophrenia. This review looks at what has been learned about MMN schizophrenia over last three decades and why level interest activity this field research remains strong. A diligent consideration available evidence suggests that can serve a biomarker schizophrenia, but perhaps not kind early supposed. concludes measurement likely to be useful monitoring response enabling tracking an underlying pathology efficacy interventions, respectively. role of, challenges presented by, pre‐clinical models discussed well merits different methodologies brought bear pursuing deeper understanding pathophysiology might explain smaller